Prenatol-m
17559a44-94b7-9ca0-e063-6294a90a2123
34391-3
HUMAN PRESCRIPTION DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Each caplet contains: Vitamin A (as Retinyl Acetate) ………………....… 1500 mcg RAE Vitamin C (as Ascorbic Acid) ………………….………… 120 mg Vitamin D3 (as Cholecalciferol).……………....... 20 mcg (800 IU) Vitamin E (as Dl-Alpha Tocopheryl Acetate) ….......….…. 13.5 mg Thiamin (as Thiamine Mononitrate) …………...…………… 3 mg Riboflavin ……………………….…………………….…. 3.4 mg Niacin (as Niacinamide) ………………..……………….… 20 mg Vitamin B6 (as Pyridoxine Hydrochloride) …....…………... 50 mg Folate (as L-5-Methyltetrahydrofolate calcium salt) ….... 2040 mcg DFE (1200 mcg as L-5-Methylfolate) Vitamin B12 (as Methylcobalamin) ……….……………... 10 mcg Choline (as Choline Bitartrate) …….……………………… 55 mg Calcium (as Calcium Carbonate) ……...…………………. 200 mg Iron (as Ferrous Fumarate) ………..……………………… 27 mg Iodine (as Potassium Iodine) …...……………………….150 mcg Magnesium (as Magnesium Oxide) …...………………… 200 mg Zinc (as Zinc Oxide) ………………...…………………….. 25 mg Selenium (as Selenium Amino Acid Chelate) ……………. 70 mcg Manganese (as Manganese Sulfate) ……………………… 2.6 mg Chromium (as Chromium Polynicotinate) ……………….. 45 mcg Molybdenum (as Molybdenum Amino Acid Chelate)…...… 50 mcg
Indications and Usage
Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.
Dosage and Administration
Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.
Contraindications
This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.
Adverse Reactions
Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Prenatol-M™ after meals may control occasional gastrointestinal disturbances. Prenatol-M™ is best absorbed when taken at bedtime. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic, and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
Drug Interactions
Prenatol-M™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).
How Supplied
Prenatol-M™ are beige speckled, oblong, coated caplets, supplied in a bottle containing 30 caplets (NDC 59088-009-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.
Medication Information
Indications and Usage
Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.
Dosage and Administration
Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.
Contraindications
This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.
Adverse Reactions
Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Prenatol-M™ after meals may control occasional gastrointestinal disturbances. Prenatol-M™ is best absorbed when taken at bedtime. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic, and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
Drug Interactions
Prenatol-M™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).
How Supplied
Prenatol-M™ are beige speckled, oblong, coated caplets, supplied in a bottle containing 30 caplets (NDC 59088-009-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.
Description
Each caplet contains: Vitamin A (as Retinyl Acetate) ………………....… 1500 mcg RAE Vitamin C (as Ascorbic Acid) ………………….………… 120 mg Vitamin D3 (as Cholecalciferol).……………....... 20 mcg (800 IU) Vitamin E (as Dl-Alpha Tocopheryl Acetate) ….......….…. 13.5 mg Thiamin (as Thiamine Mononitrate) …………...…………… 3 mg Riboflavin ……………………….…………………….…. 3.4 mg Niacin (as Niacinamide) ………………..……………….… 20 mg Vitamin B6 (as Pyridoxine Hydrochloride) …....…………... 50 mg Folate (as L-5-Methyltetrahydrofolate calcium salt) ….... 2040 mcg DFE (1200 mcg as L-5-Methylfolate) Vitamin B12 (as Methylcobalamin) ……….……………... 10 mcg Choline (as Choline Bitartrate) …….……………………… 55 mg Calcium (as Calcium Carbonate) ……...…………………. 200 mg Iron (as Ferrous Fumarate) ………..……………………… 27 mg Iodine (as Potassium Iodine) …...……………………….150 mcg Magnesium (as Magnesium Oxide) …...………………… 200 mg Zinc (as Zinc Oxide) ………………...…………………….. 25 mg Selenium (as Selenium Amino Acid Chelate) ……………. 70 mcg Manganese (as Manganese Sulfate) ……………………… 2.6 mg Chromium (as Chromium Polynicotinate) ……………….. 45 mcg Molybdenum (as Molybdenum Amino Acid Chelate)…...… 50 mcg
Storage
Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Overdose:
Iron: signs and symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis,melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Prenatol-M™ should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of the reach of children.
Warnings:
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. In case of accidental overdose, call a doctor or poison control center immediately. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.
Treatment:
For specific therapy, exchange transfusion and chelating agents should be used. For general management, gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.
Description:
Each caplet contains:
Vitamin A (as Retinyl Acetate) ………………....… 1500 mcg RAE
Vitamin C (as Ascorbic Acid) ………………….………… 120 mg
Vitamin D3 (as Cholecalciferol).……………....... 20 mcg (800 IU)
Vitamin E (as Dl-Alpha Tocopheryl Acetate) ….......….…. 13.5 mg
Thiamin (as Thiamine Mononitrate) …………...…………… 3 mg
Riboflavin ……………………….…………………….…. 3.4 mg
Niacin (as Niacinamide) ………………..……………….… 20 mg
Vitamin B6 (as Pyridoxine Hydrochloride) …....…………... 50 mg
Folate (as L-5-Methyltetrahydrofolate calcium salt) ….... 2040 mcg DFE
(1200 mcg as L-5-Methylfolate)
Vitamin B12 (as Methylcobalamin) ……….……………... 10 mcg
Choline (as Choline Bitartrate) …….……………………… 55 mg
Calcium (as Calcium Carbonate) ……...…………………. 200 mg
Iron (as Ferrous Fumarate) ………..……………………… 27 mg
Iodine (as Potassium Iodine) …...……………………….150 mcg
Magnesium (as Magnesium Oxide) …...………………… 200 mg
Zinc (as Zinc Oxide) ………………...…………………….. 25 mg
Selenium (as Selenium Amino Acid Chelate) ……………. 70 mcg
Manganese (as Manganese Sulfate) ……………………… 2.6 mg
Chromium (as Chromium Polynicotinate) ……………….. 45 mcg
Molybdenum (as Molybdenum Amino Acid Chelate)…...… 50 mcg
Precautions:
Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
For use on the order of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call
PureTek
Corporation
at
1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How Supplied:
Prenatol-M™ are beige speckled, oblong, coated caplets, supplied in a bottle containing 30 caplets (NDC 59088-009-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.
Prenatol M™
Manufactured in the USA by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free:
877-921-7873
Adverse Reactions:
Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate.
Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Prenatol-M™ after meals may control occasional gastrointestinal disturbances. Prenatol-M™ is best absorbed when taken at bedtime.
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic, and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
Contraindications:
This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.
Drug Interactions:
Prenatol-M™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).
Other Ingredients:
Croscarmellose Sodium, Crospovidone, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, Coating: Hydroxypropyl Methylcellulose [HPMC], PEG-8.
Dosage and Administration:
Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under
the age of 12.
Indications and Usage: Prenatol M™
Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years.
Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.
Structured Label Content
Storage
Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Overdose:
Iron: signs and symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis,melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Prenatol-M™ should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of the reach of children.
Warnings:
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. In case of accidental overdose, call a doctor or poison control center immediately. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.
Treatment:
For specific therapy, exchange transfusion and chelating agents should be used. For general management, gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.
Description: (DESCRIPTION:)
Each caplet contains:
Vitamin A (as Retinyl Acetate) ………………....… 1500 mcg RAE
Vitamin C (as Ascorbic Acid) ………………….………… 120 mg
Vitamin D3 (as Cholecalciferol).……………....... 20 mcg (800 IU)
Vitamin E (as Dl-Alpha Tocopheryl Acetate) ….......….…. 13.5 mg
Thiamin (as Thiamine Mononitrate) …………...…………… 3 mg
Riboflavin ……………………….…………………….…. 3.4 mg
Niacin (as Niacinamide) ………………..……………….… 20 mg
Vitamin B6 (as Pyridoxine Hydrochloride) …....…………... 50 mg
Folate (as L-5-Methyltetrahydrofolate calcium salt) ….... 2040 mcg DFE
(1200 mcg as L-5-Methylfolate)
Vitamin B12 (as Methylcobalamin) ……….……………... 10 mcg
Choline (as Choline Bitartrate) …….……………………… 55 mg
Calcium (as Calcium Carbonate) ……...…………………. 200 mg
Iron (as Ferrous Fumarate) ………..……………………… 27 mg
Iodine (as Potassium Iodine) …...……………………….150 mcg
Magnesium (as Magnesium Oxide) …...………………… 200 mg
Zinc (as Zinc Oxide) ………………...…………………….. 25 mg
Selenium (as Selenium Amino Acid Chelate) ……………. 70 mcg
Manganese (as Manganese Sulfate) ……………………… 2.6 mg
Chromium (as Chromium Polynicotinate) ……………….. 45 mcg
Molybdenum (as Molybdenum Amino Acid Chelate)…...… 50 mcg
Precautions:
Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
For use on the order of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call
PureTek
Corporation
at
1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
How Supplied:
Prenatol-M™ are beige speckled, oblong, coated caplets, supplied in a bottle containing 30 caplets (NDC 59088-009-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.
Prenatol M™ (Prenatol-M™)
Manufactured in the USA by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free:
877-921-7873
Adverse Reactions:
Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate.
Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Prenatol-M™ after meals may control occasional gastrointestinal disturbances. Prenatol-M™ is best absorbed when taken at bedtime.
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic, and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
Contraindications:
This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.
Drug Interactions:
Prenatol-M™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).
Other Ingredients:
Croscarmellose Sodium, Crospovidone, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, Coating: Hydroxypropyl Methylcellulose [HPMC], PEG-8.
Dosage and Administration:
Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under
the age of 12.
Indications and Usage: Prenatol M™ (Indications and Usage: Prenatol-M™)
Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years.
Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T11:40:59.134205 · Updated: 2026-03-14T22:04:41.081691